Moving toward genetic profiling in patient care: the scope and rationale of pharmacogenetic/ecogenetic investigation.
Alvan
G
G
Division of Clinical Pharmacology, Department of Medical Laboratory Science and Technology, Huddinge University Hospital, S-141 86 Huddinge, Sweden. gunnar.alvan@mpa.se
Bertilsson
L
L
Dahl
M L
ML
Ingelman-Sundberg
M
M
Sjöqvist
F
F
D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics / Q000378:metabolism; D003647:Debrisoquin / Q000378:metabolism; D005006:Ethnicity / Q000235:genetics; D005820:Genetic Testing; D006801:Humans; D006900:Hydroxylation; D008617:Mephenytoin / Q000378:metabolism; D005791:Patient Care; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic; D013034:Sparteine / Q000378:metabolism
D013034:Sparteine; D019389:Cytochrome P-450 CYP2D6; D008617:Mephenytoin; D003647:Debrisoquin